Pattern Recognition by Toll-like Receptors

  • Stefan Bauer
  • Thomas Müller
  • Svetlana Hamm
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 653)


The mammalian immune system senses pathogens through pattern recognition receptors and responds with activation. The Toll-like receptors (TLRs) that are expressed on antigen presenting cells such as macrophages and dendritic cells play a critical role in this process. Their signaling activates these cells and leads to an innate immune response with subsequent initiation of an adaptive immune response. Each TLR recognizes specific structures and induces common inflammatory cytokines. However, some TLRs have specific functions, such as induction of Type I interferons. The TLR dependent cytokine response is reflected in the induction of common and specific signaling pathways leading to adequate immune responses for different pathogens. Some TLRs are also activated by endogenous structures that are released during infection, but these structures may promote or sustain autoimmune diseases under certain circumstances. In addition, TLRs direcdy shape adaptive immune responses of T and B cells and play an important role in homeostasis of gut epithelium and lung repair after injury.


Systemic Lupus Erythematosus Dendritic Cell Treg Cell West Nile Virus Innate Immune System 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Medzhitov R, Janeway Jr CA. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997; 91:295–298.PubMedCrossRefGoogle Scholar
  2. 2.
    Janeway Jr CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197–216.PubMedCrossRefGoogle Scholar
  3. 3.
    Rock FL, Hardiman G, Timans JC et al. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 1998; 95:588–593.PubMedCrossRefGoogle Scholar
  4. 4.
    Anderson KV, Bokla L, Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: The induction of polarity by the Toll gene product. Cell 1985; 42:791–798.PubMedCrossRefGoogle Scholar
  5. 5.
    Lemaitre B, Nicolas E, Michaut L et al. The dorsoventral regulatory gene cassette spatzle/Toll/ cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86:973–983.PubMedCrossRefGoogle Scholar
  6. 6.
    Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 2005; 17:1–14.PubMedCrossRefGoogle Scholar
  7. 7.
    Tabeta K, Georgel P, Janssen E et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 2004; 101:3516–3521.PubMedCrossRefGoogle Scholar
  8. 8.
    Medzhitov R, Janeway Jr C. Innate immunity. N Engl J Med 2000; 343:338–344.PubMedCrossRefGoogle Scholar
  9. 9.
    Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001; 7:167–202.PubMedGoogle Scholar
  10. 10.
    Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282:2085–2088.PubMedCrossRefGoogle Scholar
  11. 11.
    Heumann D, Lauener R, Ryffel B. The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds. J Endotoxin Res 2003; 9:381–384.PubMedGoogle Scholar
  12. 12.
    Shimazu R, Akashi S, Ogata H et al. MD-2 a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189:1777–1782.PubMedCrossRefGoogle Scholar
  13. 13.
    Girard R, Pedron T, Uematsu S et al. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J Cell Sci 2003; 116:293–302.PubMedCrossRefGoogle Scholar
  14. 14.
    Werts C, Tapping RJ, Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2:346–352.PubMedCrossRefGoogle Scholar
  15. 15.
    Akamine M, Higa F, Arakaki N et al. Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila. Infect Immun 2005; 73:352–361.PubMedCrossRefGoogle Scholar
  16. 16.
    Asai Y, Hashimoto M, Fletcher HM et al. Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked decrease in toll-like receptor 2-mediated signaling. Infect Immun 2005; 73:2157–2163.PubMedCrossRefGoogle Scholar
  17. 17.
    Takeuchi O, Hoshino K, Kawai T et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11:443–451.PubMedCrossRefGoogle Scholar
  18. 18.
    Schwandner R, Dziarski R, Wesche H et al. Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274:17406–17409.PubMedCrossRefGoogle Scholar
  19. 19.
    Alexopoulou L, Thomas V, Schnare M et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1and TLR2-deficient mice. Nat Med 2002; 8:878–884.PubMedGoogle Scholar
  20. 20.
    Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000; 97:13766–13771.PubMedCrossRefGoogle Scholar
  21. 21.
    Takeuchi O, Sato S, Horiuchi T et al. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169:10–14.PubMedGoogle Scholar
  22. 22.
    Takeuchi O, Kawai T, Muhlradt PF et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 2001; 13:933–940.PubMedCrossRefGoogle Scholar
  23. 23.
    Buwitt-Beckmann U, Heine H, Wiesmuller KH et al. TLR1-and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 2006; 281:9049–9057.PubMedCrossRefGoogle Scholar
  24. 24.
    Michelsen KS, Aicher A, Mohaupt M et al. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 2001; 276:25680–25686.PubMedCrossRefGoogle Scholar
  25. 25.
    Travassos LH, Girardin SE, Philpott DJ et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 2004; 5:1000–1006.PubMedCrossRefGoogle Scholar
  26. 26.
    Chamaillard M, Hashimoto M, Horie Y et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003; 4:702–707.PubMedCrossRefGoogle Scholar
  27. 27.
    Girardin SE, Boneca IG, Carneiro LA et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003; 300:1584–1587.PubMedCrossRefGoogle Scholar
  28. 28.
    Girardin SE, Boneca IG, Viala J et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278:8869–8872.PubMedCrossRefGoogle Scholar
  29. 29.
    Inohara N, Ogura Y, Fontalba A et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem 2003; 278:5509–5512.PubMedCrossRefGoogle Scholar
  30. 30.
    Echchannaoui H, Bachmann P, Letiembre M et al. Regulation of Streptococcus pneumoniae distribution by Toll-like receptor 2 in vivo. Immunobiology 2005; 210:229–236.PubMedCrossRefGoogle Scholar
  31. 31.
    Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165:5392–5396.PubMedGoogle Scholar
  32. 32.
    Woods JP, Frelinger JA, Warrack G et al. Mouse genetic locus Lps influences susceptibility to Neisseria meningitidis infection. Infect Immun 1988; 56:1950–1955.PubMedGoogle Scholar
  33. 33.
    Weinstein DL, Lissner CR, Swanson RN et al. Macrophage defect and inflammatory cell recruitment dysfunction in Salmonella susceptible C3H/HeJ mice. Cell Immunol 1986; 102:68–77.PubMedCrossRefGoogle Scholar
  34. 34.
    Bernheiden M, Heinrich JM, Minigo G et al. LBP CD14 TLR4 and the murine innate immune response to a peritoneal Salmonella infection. J Endotoxin Res 2001; 7:447–450.PubMedGoogle Scholar
  35. 35.
    Zhang D, Zhang G, Hayden MS et al. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303:1522–1526.PubMedCrossRefGoogle Scholar
  36. 36.
    Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410:1099–1103.PubMedCrossRefGoogle Scholar
  37. 37.
    Smith KD, Andersen-Nissen E, Hayashi F et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 2003; 4:1247–1253.PubMedCrossRefGoogle Scholar
  38. 38.
    Gewirtz AT, Navas TA, Lyons S et al. Cutting edge: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167:1882–1885.PubMedGoogle Scholar
  39. 39.
    Means TK, Hayashi F, Smith KD et al. The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells. J Immunol 2003; 170:5165–5175.PubMedGoogle Scholar
  40. 40.
    Cabral ES, Gelderblom H, Hornung RL et al. Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes. J Infect Dis 2006; 193:849–859.PubMedCrossRefGoogle Scholar
  41. 41.
    Subramanian N, Qadri A. Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella. Nat Immunol 2006; 7:583–589.PubMedCrossRefGoogle Scholar
  42. 42.
    Hawn TR, Verbon A, Lettinga KD et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires’ disease. J Exp Med 2003; 198:1563–1572.PubMedCrossRefGoogle Scholar
  43. 43.
    Andersen-Nissen E, Smith KD, Strobe KL et al. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 2005; 102:9247–9252.PubMedCrossRefGoogle Scholar
  44. 44.
    Tokunaga T, Yamamoto H, Shimada S et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation physicochemical characterization and antitumor activity. J Natl Cancer Inst 1984; 72:955–962.PubMedGoogle Scholar
  45. 45.
    Krieg AM, Yi AK, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546–549.PubMedCrossRefGoogle Scholar
  46. 46.
    Wagner H. Toll meets bacterial CpG-DNA. Immunity 2001; 14:499–502.PubMedCrossRefGoogle Scholar
  47. 47.
    Kalis C, Gumenscheimer M, Freudenberg N et al. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes. J Immunol 2005; 174:4295–4300.PubMedGoogle Scholar
  48. 48.
    Kurt-Jones EA, Popova L, Kwinn L et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000; 1:398–401.PubMedCrossRefGoogle Scholar
  49. 49.
    Haynes LM, Moore DD, Kurt-Jones EA et al. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 2001; 75:10730–10737.PubMedCrossRefGoogle Scholar
  50. 50.
    Rassa JC, Meyers JL, Zhang Y et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci USA 2002; 99:2281–2286.PubMedCrossRefGoogle Scholar
  51. 51.
    Jude BA, Pobezinskaya Y, Bishop J et al. Subversion of the innate immune system by a retrovirus. Nat Immunol 2003; 4:573–578.PubMedCrossRefGoogle Scholar
  52. 52.
    Ehl S, Bischoff R, Ostler T et al. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur J Immunol 2004; 34:1146–1153.PubMedCrossRefGoogle Scholar
  53. 53.
    Burzyn D, Rassa JC, Kim D et al. Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J Virol 2004; 78:576–584.PubMedCrossRefGoogle Scholar
  54. 54.
    Bieback K, Lien E, Klagge IM et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 2002; 76:8729–8736.PubMedCrossRefGoogle Scholar
  55. 55.
    Aravalli RN, Hu S, Rowen TN et al. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 2005; 175:4189–4193.PubMedGoogle Scholar
  56. 56.
    Kurt-Jones EA, Chan M, Zhou S et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci USA 2004; 101:1315–1320.PubMedCrossRefGoogle Scholar
  57. 57.
    Compton T, Kurt-Jones EA, Boehme KW et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003; 77:4588–4596.PubMedCrossRefGoogle Scholar
  58. 58.
    Garcia-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: A lesson in detente. Science 2006; 312:879–882.PubMedCrossRefGoogle Scholar
  59. 59.
    Lund J, Sato A, Akira S et al. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198:513–520.PubMedCrossRefGoogle Scholar
  60. 60.
    Krug A, French AR, Barchet W et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004; 21:107–119.PubMedCrossRefGoogle Scholar
  61. 61.
    Hochrein H, Schlatter B, O’Keeffe M et al. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and-independent pathways. Proc Natl Acad Sci USA 2004; 101:11416–11421.PubMedCrossRefGoogle Scholar
  62. 62.
    Krug A, Luker GD, Barchet W et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004; 103:1433–1437.PubMedCrossRefGoogle Scholar
  63. 63.
    Siegal FP, Kadowaki N, Shodell M et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999; 284:1835–1837.PubMedCrossRefGoogle Scholar
  64. 64.
    Malmgaard L, Melchjorsen J, Bowie AG et al. Viral activation of macrophages through TLR-dependent and-independent pathways. J Immunol 2004; 173:6890–6898.PubMedGoogle Scholar
  65. 65.
    Heil F, Hemmi H, Hochrein H et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303:1526–1529.PubMedCrossRefGoogle Scholar
  66. 66.
    Diebold SS, Kaisho T, Hemmi H et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303:1529–1531.PubMedCrossRefGoogle Scholar
  67. 67.
    Lund JM, Alexopoulou L, Sato A et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 2004; 101:5598–5603.PubMedCrossRefGoogle Scholar
  68. 68.
    Kato H, Sato S, Yoneyama M et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005; 23:19–28.PubMedCrossRefGoogle Scholar
  69. 69.
    Triantafilou K, Orthopoulos G, Vakakis E et al. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol 2005; 7:1117–1126.PubMedCrossRefGoogle Scholar
  70. 70.
    Triantafilou K, Vakakis E, Orthopoulos G et al. TLR8 and TLR7 are involved in the host’s immune response to human parechovirus 1. Eur J Immunol 2005; 35:2416–2423.PubMedCrossRefGoogle Scholar
  71. 71.
    Chuang TH, Ulevitch RJ. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7 hTLR8 and hTLR9. Eur Cytokine Netw 2000; 11:372–378.PubMedGoogle Scholar
  72. 72.
    Du X, Poltorak A, Wei Y et al. Three novel mammalian toll-like receptors: Gene structure expression and evolution. Eur Cytokine Netw 2000; 11:362–371.PubMedGoogle Scholar
  73. 73.
    Hemmi H, Kaisho T, Takeuchi O et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002; 3:196–200.PubMedCrossRefGoogle Scholar
  74. 74.
    Jurk M, Heil F, Vollmer J et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002; 3:499.PubMedCrossRefGoogle Scholar
  75. 75.
    Heil F, Ahmad-Nejad P, Hemmi H et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7 8 and 9 subfamily. Eur J Immunol 2003; 33:2987–2997.PubMedCrossRefGoogle Scholar
  76. 76.
    Lee J, Chuang TH, Redecke V et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7. Proc Natl Acad Sci USA 2003; 100:6646–6651.PubMedCrossRefGoogle Scholar
  77. 77.
    Yoneyama M, Kikuchi M, Natsukawa T et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5:730–737.PubMedCrossRefGoogle Scholar
  78. 78.
    Gitlin L, Barchet W, Gilfillan S et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 2006; 103:8459–8464.PubMedCrossRefGoogle Scholar
  79. 79.
    Kato H, Takeuchi O, Sato S et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101–105.PubMedCrossRefGoogle Scholar
  80. 80.
    Yang K, Puel A, Zhang S et al. Human TLR-7-8-and-9-mediated induction of IFN-alpha/beta and-lambda Is IRAK-4 dependent and redundant for protective immunity to viruses. Immunity 2005; 23:465–478.PubMedCrossRefGoogle Scholar
  81. 81.
    Alexopoulou L, Holt AC, Medzhitov R et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001; 413:732–738.PubMedCrossRefGoogle Scholar
  82. 82.
    Matsumoto M, Funami K, Oshiumi H et al. Toll-like receptor 3: A link between toll-like receptor interferon and viruses. Microbiol Immunol 2004; 48:147–154.PubMedGoogle Scholar
  83. 83.
    Edelmann KH, Richardson-Burns S, Alexopoulou L et al. Does Toll-like receptor 3 play a biological role in virus infections? Virology 2004; 322:231–238.PubMedCrossRefGoogle Scholar
  84. 84.
    Wang T, Town T, Alexopoulou L et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004; 10:1366–1373.PubMedCrossRefGoogle Scholar
  85. 85.
    Schulz O, Diebold SS, Chen M et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005; 433:887–892.PubMedCrossRefGoogle Scholar
  86. 86.
    Loseke S, Grage-Griebenow E, Heine H et al. In vitro-generated viral double-stranded RNA in contrast to polyinosinic: Polycytidylic acid induces interferon-alpha in human plasmacytoid dendritic cells. Scand J Immunol 2006; 63:264–274.PubMedCrossRefGoogle Scholar
  87. 87.
    Underhill DM, Ozinsky A, Hajjar AM et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401:811–815.PubMedCrossRefGoogle Scholar
  88. 88.
    Netea MG, Van der Graaf CA, Vonk AG et al. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002; 185:1483–1489.PubMedCrossRefGoogle Scholar
  89. 89.
    Meier A, Kirschning CJ, Nikolaus T et al. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol 2003; 5:561–570.PubMedCrossRefGoogle Scholar
  90. 90.
    Jouault T, Ibata-Ombetta S, Takeuchi O et al. Candida albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis 2003; 188:165–172.PubMedCrossRefGoogle Scholar
  91. 91.
    Levitz SM. Interactions of Toll-like receptors with fungi. Microbes Infect 2004; 6:1351–1355.PubMedCrossRefGoogle Scholar
  92. 92.
    Netea MG, Sutmuller R, Hermann C et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004; 172:3712–3718.PubMedGoogle Scholar
  93. 93.
    Netea MG, Warris A, Van der Meer JW et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003; 188:320–326.PubMedCrossRefGoogle Scholar
  94. 94.
    Gantner BN, Simmons RM, Canavera SJ et al. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 2003; 197:1107–1117.PubMedCrossRefGoogle Scholar
  95. 95.
    Brown GD. Dectin-1: A signalling nonTLR pattern-recognition receptor. Nat Rev Immunol 2006; 6:33–43.PubMedCrossRefGoogle Scholar
  96. 96.
    Brown GD, Taylor PR, Reid DM et al. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 2002; 196:407–412.PubMedCrossRefGoogle Scholar
  97. 97.
    Rogers NC, Slack EC, Edwards AD et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 2005; 22:507–517.PubMedCrossRefGoogle Scholar
  98. 98.
    Gantner BN, Simmons RM, Underhill DM. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 2005; 24:1277–1286.PubMedCrossRefGoogle Scholar
  99. 99.
    Campos MA, Almeida IC, Takeuchi O et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001; 167:416–423.PubMedGoogle Scholar
  100. 100.
    Mun HS, Aosai F, Norose K et al. TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 2003; 15:1081–1087.PubMedCrossRefGoogle Scholar
  101. 101.
    de Veer MJ, Curtis JM, Baldwin TM et al. MyD88 is essential for clearance of Leishmania major: Possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur J Immunol 2003; 33:2822–2831.PubMedCrossRefGoogle Scholar
  102. 102.
    Kropf P, Freudenberg MA, Modolell M et al. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect Immun 2004; 72:1920–1928.PubMedCrossRefGoogle Scholar
  103. 103.
    Oliveira AC, Peixoto JR, de Arruda LB et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol 2004; 173:5688–5696.PubMedGoogle Scholar
  104. 104.
    Yarovinsky F, Zhang D, Andersen JF et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005; 308:1626–1629.PubMedCrossRefGoogle Scholar
  105. 105.
    Pichyangkul S, Yongvanitchit K, Kum-arb U et al. Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol 2004; 172:4926–4933.PubMedGoogle Scholar
  106. 106.
    Coban C, Ishii KJ, Kawai T et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 2005; 201:19–25.PubMedCrossRefGoogle Scholar
  107. 107.
    Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 2004; 25:381–386.PubMedCrossRefGoogle Scholar
  108. 108.
    Latz E, Schoenemeyer A, Visintin A et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5:190–198.PubMedCrossRefGoogle Scholar
  109. 109.
    Leifer CA, Kennedy MN, Mazzoni A et al. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol 2004; 173:1179–1183.PubMedGoogle Scholar
  110. 110.
    Rutz M, Metzger J, Gellert T et al. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence-and pH-dependent manner. Eur J Immunol 2004; 34:2541–2550.PubMedCrossRefGoogle Scholar
  111. 111.
    Yi AK, Peckham DW, Ashman RF et al. CpG DNA rescues B cells from apoptosis by activating NFkappaB and preventing mitochondrial membrane potential disruption via a chloroquine-sensitive pathway. Int Immunol 1999; 11:2015–2024.PubMedCrossRefGoogle Scholar
  112. 112.
    Hacker H, Mischak H, Miethke T et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by nonspecific endocytosis and endosomal maturation. EMBO J 1998; 17:6230–6240.PubMedCrossRefGoogle Scholar
  113. 113.
    Funami K, Matsumoto M, Oshiumi H et al. The cytoplasmic ‘linker region’ in Toll-like receptor 3 controls receptor localization and signaling. Int Immunol 2004; 16:1143–1154.PubMedCrossRefGoogle Scholar
  114. 114.
    Nishiya T, Kajita E, Miwa S et al. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J Biol Chem 2005; 280:37107–37117.PubMedCrossRefGoogle Scholar
  115. 115.
    Kajita E, Nishiya T, Miwa S. The transmembrane domain directs TLR9 to intracellular compartments that contain TLR3. Biochem Biophys Res Commun 2006; 343:578–584.PubMedCrossRefGoogle Scholar
  116. 116.
    Barton GM, Kagan JC, Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 2006; 7:49–56.PubMedCrossRefGoogle Scholar
  117. 117.
    Kariko K, Buckstein M, Ni H et al. Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005; 23:165–175.PubMedCrossRefGoogle Scholar
  118. 118.
    Ishii KJ, Akira S. TLR ignores methylated RNA? Immunity 2005; 23:111–113.PubMedCrossRefGoogle Scholar
  119. 119.
    Leadbetter EA, Rifltin IR, Hohlbaum AM et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002; 416:603–607.PubMedCrossRefGoogle Scholar
  120. 120.
    Viglianti GA, Lau CM, Hanley TM et al. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003; 19:837–847.PubMedCrossRefGoogle Scholar
  121. 121.
    Beg AA. Endogenous ligands of Toll-like receptors: Implications for regulating inflammatory and immune responses. Trends Immunol 2002; 23:509–512.PubMedCrossRefGoogle Scholar
  122. 122.
    Seong SY, Matzinger P. Hydrophobicity: An ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4:469–478.PubMedCrossRefGoogle Scholar
  123. 123.
    Vabulas RM, Ahmad-Nejad P, da Costa C et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001; 276:31332–31339.PubMedCrossRefGoogle Scholar
  124. 124.
    Vabulas RM, Braedel S, Hilf N et al. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J Biol Chem 2002; 277:20847–20853.PubMedCrossRefGoogle Scholar
  125. 125.
    Habich C, Baumgart K, Kolb H et al. The receptor for heat shock protein 60 on macrophages is saturable specific and distinct from receptors for other heat shock proteins. J Immunol 2002; 168:569–576.PubMedGoogle Scholar
  126. 126.
    Vabulas RM, Ahmad-Nejad P, Ghose S et al. HSP70 as endogenous stimulus of the Toll/ interleukin-1 receptor signal pathway. J Biol Chem 2002; 277:15107–15112.PubMedCrossRefGoogle Scholar
  127. 127.
    Flohe SB, Bruggemann J, Lendemans S et al. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J Immunol 2003; 170:2340–2348.PubMedGoogle Scholar
  128. 128.
    Multhoff G. Heat shock proteins in immunity. Handb Exp Pharmacol 2006; 279–304.Google Scholar
  129. 129.
    Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167:2887–2894.PubMedGoogle Scholar
  130. 130.
    Guillot L, Balloy V, McCormack FX et al. Cutting edge: The immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002; 168:5989–5992.PubMedGoogle Scholar
  131. 131.
    Okamura Y, Watari M, Jerud ES et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001; 276:10229–10233.PubMedCrossRefGoogle Scholar
  132. 132.
    Johnson GB, Brunn GJ, Kodaira Y et al. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002; 168:5233–5239.PubMedGoogle Scholar
  133. 133.
    Termeer C, Benedix F, Sleeman J et al. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195:99–111.PubMedCrossRefGoogle Scholar
  134. 134.
    Biragyn A, Ruffini PA, Leifer CA et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002; 298:1025–1029.PubMedCrossRefGoogle Scholar
  135. 135.
    Park JS, Svetkauskaite D, He Q et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279:7370–7377.PubMedCrossRefGoogle Scholar
  136. 136.
    Gao B, Tsan MF. Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J Biol Chem 2003; 278:22523–22529.PubMedCrossRefGoogle Scholar
  137. 137.
    Gao B, Tsan MF. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem 2003; 278:174–179.PubMedCrossRefGoogle Scholar
  138. 138.
    Liu B, Dai J, Zheng H et al. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc Natl Acad Sci USA 2003; 100:15824–15829.PubMedCrossRefGoogle Scholar
  139. 139.
    Elias D, Reshef T, Birk OS et al. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci USA 1991; 88:3088–3091.PubMedCrossRefGoogle Scholar
  140. 140.
    Pockley AG. Heat shock proteins inflammation and cardiovascular disease. Circulation 2002; 105:1012–1017.PubMedCrossRefGoogle Scholar
  141. 141.
    Pope RM, Lovis RM, Gupta RS. Activation of synovial fluid T lymphocytes by 60-kd heat-shock proteins in patients with inflammatory synovitis. Arthritis Rheum 1992; 35:43–48.PubMedCrossRefGoogle Scholar
  142. 142.
    Jiang D, Liang J, Fan J et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005; 11:1173–1179.PubMedCrossRefGoogle Scholar
  143. 143.
    Ronnblom L, Alm GV. Systemic lupus erythematosus and the type I interferon system. Arthritis ResTher 2003; 5:68–75.CrossRefGoogle Scholar
  144. 144.
    Migliorini P, Baldini C, Rocchi V et al. Anti-Sm and anti-RNP antibodies. Autoimmunity 2005; 38:47–54.PubMedCrossRefGoogle Scholar
  145. 145.
    Leadbetter EA, Rifkin IR, Marshak-Rothstein A. Toll-like receptors and activation of autoreactive B cells. Curr Dir Autoimmun 2003; 6:105–122.PubMedCrossRefGoogle Scholar
  146. 146.
    Boule MW, Broughton C, Mackay F et al. Toll-like receptor 9-dependent and-independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004; 199:1631–1640.PubMedCrossRefGoogle Scholar
  147. 147.
    Lau CM, Broughton C, Tabor AS et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005; 202:1171–1177.PubMedCrossRefGoogle Scholar
  148. 148.
    Means TK, Latz E, Hayashi F et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005; 115:407–417.PubMedGoogle Scholar
  149. 149.
    Vollmer J, Tluk S, Schmitz C et al. Immune Stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005; 202:1575–1585.PubMedCrossRefGoogle Scholar
  150. 150.
    Barrat FJ, Meeker T, Gregorio J et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 2005; 202:1131–1139.PubMedCrossRefGoogle Scholar
  151. 151.
    Savarese E, Chae OW, Trowitzsch S et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 2006; 107:3229–3234.PubMedCrossRefGoogle Scholar
  152. 152.
    Christensen SR, Kashgarian M, Alexopoulou L et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 2005; 202:321–331.PubMedCrossRefGoogle Scholar
  153. 153.
    Wu X, Peng SL. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 2006; 54:336–342.PubMedCrossRefGoogle Scholar
  154. 154.
    Yasuda K, Rutz M, Schlatter B et al. CpG motif-independent activation of TLR9 upon endosomal translocation of „natural“ phosphodiester DNA. Eur J Immunol 2006; 36:431–436.PubMedCrossRefGoogle Scholar
  155. 155.
    Cabral AR, Alarcon-Segovia D. Autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 1997; 9:387–392.PubMedCrossRefGoogle Scholar
  156. 156.
    Pisitkun P, Deane JA, Difilippantonio MJ et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006; 312:1669–1672.PubMedCrossRefGoogle Scholar
  157. 157.
    O’Neill LA. How Toll-like receptors signal: What we know and what we don’t know. Curr Opin Immunol 2006; 18:3–9.PubMedCrossRefGoogle Scholar
  158. 158.
    O’Neill LA, Greene C. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals insects and plants. J Leukoc Biol 1998; 63:650–657.PubMedGoogle Scholar
  159. 159.
    Medzhitov R, Preston-Hurlburt P, Janeway Jr CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388:394–397.PubMedCrossRefGoogle Scholar
  160. 160.
    Wesche H, Henzel WJ, Shillinglaw W et al. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997; 7:837–847.PubMedCrossRefGoogle Scholar
  161. 161.
    Burns K, Martinon F, Esslinger C et al. MyD88 an adapter protein involved in interleukin-1 signaling. J Biol Chem 1998; 273:12203–12209.PubMedCrossRefGoogle Scholar
  162. 162.
    Adachi O, Kawai T, Takeda K et al. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 1998; 9:143–150.PubMedCrossRefGoogle Scholar
  163. 163.
    Medzhitov R, Preston-Hurlburt P, Kopp E et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 1998; 2:253–258.PubMedCrossRefGoogle Scholar
  164. 164.
    Horng T, Barton GM, Medzhitov R. TIRAP: An adapter molecule in the Toll signaling pathway. Nat Immunol 2001; 2:835–841.PubMedCrossRefGoogle Scholar
  165. 165.
    Fitzgerald KA, Palsson-McDermott EM, Bowie AG et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001; 413:78–83.PubMedCrossRefGoogle Scholar
  166. 166.
    Yamamoto M, Sato S, Mori K et al. Cutting edge: A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002; 169:6668–6672.PubMedGoogle Scholar
  167. 167.
    Oshiumi H, Matsumoto M, Funami K et al. TICAM-1 an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003; 4:161–167.PubMedCrossRefGoogle Scholar
  168. 168.
    Yamamoto M, Sato S, Hemmi H et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003; 4:1144–1150.PubMedCrossRefGoogle Scholar
  169. 169.
    Cao Z, Xiong J, Takeuchi M et al. TRAF6 is a signal transducer for interleukin-1. Nature 1996; 383:443–446.PubMedCrossRefGoogle Scholar
  170. 170.
    Muzio M, Natoli G, Saccani S et al. The human toll signaling pathway: Divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 1998; 187:2097–2101.PubMedCrossRefGoogle Scholar
  171. 171.
    Li S, Strelow A, Fontana EJ et al. IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci USA 2002; 99:5567–5572.PubMedCrossRefGoogle Scholar
  172. 172.
    Wang C, Deng L, Hong M et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412:346–351.PubMedCrossRefGoogle Scholar
  173. 173.
    Hacker H, Redecke V, Blagoev B et al. Specificity in Toll-like receptor ÿignaling through distinct effector functions of TRAF3 and TRAF6. Nature. 2006; 439:204–207.PubMedCrossRefGoogle Scholar
  174. 174.
    Oganesyan G, Saha SK, Guo B et al. Critical role of TRAF3 in the Toll-like receptor-dependent and-independent antiviral response. Nature 2006; 439:208–211.PubMedCrossRefGoogle Scholar
  175. 175.
    Takaoka A, Yanai H, Kondo S et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434:243–249.PubMedCrossRefGoogle Scholar
  176. 176.
    Hoebe K, Du X, Georgel P et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signaling. Nature 2003; 424:743–748.PubMedCrossRefGoogle Scholar
  177. 177.
    Yamamoto M, Sato S, Hemmi H et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003; 301:640–643.PubMedCrossRefGoogle Scholar
  178. 178.
    Meylan E, Burns K, Hofmann K et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 2004; 5:503–507.PubMedCrossRefGoogle Scholar
  179. 179.
    Fitzgerald KA, Rowe DC, Barnes BJ et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 2003; 198:1043–1055.PubMedCrossRefGoogle Scholar
  180. 180.
    Sharma S, tenOever BR, Grandvaux N et al. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003; 300:1148–1151.PubMedCrossRefGoogle Scholar
  181. 181.
    Honda K, Yanai H, Negishi H et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434:772–777.PubMedCrossRefGoogle Scholar
  182. 182.
    Sakaguchi S, Negishi H, Asagiri M et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock. Biochem Biophys Res Commun 2003; 306:860–866.PubMedCrossRefGoogle Scholar
  183. 183.
    Honda K, Yanai H, Mizutani T et al. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci USA 2004; 101:15416–15421.PubMedCrossRefGoogle Scholar
  184. 184.
    Kawai T, Sato S, Ishii KJ et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5:1061–1068.PubMedCrossRefGoogle Scholar
  185. 185.
    Uematsu S, Sato S, Yamamoto M et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7-and TLR9-mediated interferon-{alpha} induction. J Exp Med 2005; 201:915–923.PubMedCrossRefGoogle Scholar
  186. 186.
    Hoshino K, Sugiyama T, Matsumoto M et al. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature 2006; 440:949–953.PubMedCrossRefGoogle Scholar
  187. 187.
    Kobe B, Deisenhofer J. Proteins with leucine-rich repeats. Curr Opin Struct Biol 1995; 5:409–416.PubMedCrossRefGoogle Scholar
  188. 188.
    Bell JK, Mullen GE, Leifer CA et al. Leucine-rich repeats and pathogen recognition in Toll-like receptors. Trends Immunol 2003; 24:528–533.PubMedCrossRefGoogle Scholar
  189. 189.
    Bell JK, Botos I, Hall PR et al. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc Natl Acad Sci USA 2005; 102:10976–10980.PubMedCrossRefGoogle Scholar
  190. 190.
    Choe J, Kelker MS, Wilson IA. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 2005; 309:581–585.PubMedCrossRefGoogle Scholar
  191. 191.
    Bell JK, Askins J, Hall PR et al. The dsRNA binding site of human Toll-like receptor 3. Proc Natl Acad Sci USA 2006; 103:8792–8797.PubMedCrossRefGoogle Scholar
  192. 192.
    Kaisho T, Akira S. Regulation of dendritic cell function through toll-like receptors. Curr Mol Med 2003; 3:759–771.PubMedCrossRefGoogle Scholar
  193. 193.
    Sivori S, Falco M, Delia CM et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 2004; 101:10116–10121.PubMedCrossRefGoogle Scholar
  194. 194.
    Parker LC, Whyte MK, Dower SK et al. The expression and roles of Toll-like receptors in the biology of the human neutrophil. J Leukoc Biol 2005; 77:886–892.PubMedCrossRefGoogle Scholar
  195. 195.
    Nagase H, Okugawa S, Ota Y et al. Expression and function of Toll-like receptors in eosinophils: Activation by Toll-like receptor 7 ligand. J Immunol 2003; 171:3977–3982.PubMedGoogle Scholar
  196. 196.
    Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: An overview. Methods Mol Biol 2006; 315:13–34.PubMedGoogle Scholar
  197. 197.
    Ruprecht CR, Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 2006; 36:810–816.PubMedCrossRefGoogle Scholar
  198. 198.
    Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 2005; 438:364–368.PubMedCrossRefGoogle Scholar
  199. 199.
    Xu D, Komai-Koma M, Liew FY. Expression and function of Toll-like receptor on T cells. Cell Immunol 2005; 233:85–89.PubMedCrossRefGoogle Scholar
  200. 200.
    Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299:1033–1036.PubMedCrossRefGoogle Scholar
  201. 201.
    Peng G, Guo Z, Kiniwa Y et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005; 309:1380–1384.PubMedCrossRefGoogle Scholar
  202. 202.
    Sutmuller RP, den Brok MH, Kramer M et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116:485–494.PubMedCrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2009

Authors and Affiliations

  • Stefan Bauer
    • 1
  • Thomas Müller
    • 1
  • Svetlana Hamm
    • 1
  1. 1.Institut für Medizinische MikrobiologieImmunologie und Hygiene, Technische Universität MünchenMünchenGermany

Personalised recommendations